Solnul Potato Starch Secures European Distribution with Lehvoss Group Deal
Canada's MSP Starch Products has partnered with Lehvoss Group for exclusive European distribution of its Solnul resistant potato starch, targeting the growing prebiotic market and low fiber intake.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 10 April 2026
MSP Starch Products Inc. has established an exclusive distribution partnership with Germany's Lehvoss Group, formalising the European market access for its Solnul-branded resistant potato starch. This move signals a strategic shift from Solnul’s previous direct supply model, such as its arrangement with Sunday Natural. The collaboration positions Solnul to capitalise on increasing European consumer interest in prebiotic ingredients and dietary fibres, particularly within the German and UK markets, where current resistant starch intake is below optimal levels. The ingredient, supported by research indicating improved gut microbiome composition, metabolic markers, and nutrient absorption at a 3.5g/day dosage, now benefits from established supply chain infrastructure.
Lehvoss Group, with its extensive network and regulatory expertise across Europe, will facilitate broader market penetration for Solnul. This partnership directly addresses the industry's challenge in sourcing novel, clinically supported ingredients for gut health formulations. For brand owners, the deal simplifies procurement pathways, potentially reducing lead times and minimum order quantities (MOQs) compared to direct international sourcing. The focus on resistant potato starch provides a differentiated offering within the crowded fibre and prebiotic segment, aligning with cleaner label trends due to its natural origin.
Market research consistently highlights a gap between consumer awareness of gut health benefits and actual dietary intake of beneficial fibres. Solnul's expansion aims to bridge this gap by making an effective ingredient more accessible to manufacturers. The partnership could trigger increased competition within the European prebiotic ingredient sector, prompting other suppliers to innovate or expand their distribution networks to maintain market share. This move also underscores a broader trend of ingredient suppliers seeking regional distribution specialists to navigate complex European regulatory and logistical environments.
What this means for United Kingdom
UK brand owners will see enhanced access to Solnul via Lehvoss, streamlining procurement and reducing import complexities. This ingredient offers a specific and substantiated claim for gut microbiome support that can differentiate new product developments in a competitive market. Formulators should consider integrating Solnul into products targeting digestive health, weight management, or blood sugar control, leveraging its 3.5g daily dose efficacy. The partnership could also stimulate an increase in fibre-fortified food and supplement innovation in the UK, creating opportunities for brands to capture market share within the growing health & wellness sector.
The market for functional ingredients in the UK is increasingly driven by scientific substantiation and clear health benefits, aligning well with Solnul's profile. Brands should prepare for potential competitor responses as other ingredient suppliers seek to strengthen their UK distribution channels or launch similar offerings.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.